Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Gabapentin
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Anxiety=== There is a small amount of research on the use of gabapentin for the treatment of anxiety disorders.<ref name="pmid17502773">{{cite journal | vauthors = Mula M, Pini S, Cassano GB | title = The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence | journal = Journal of Clinical Psychopharmacology | volume = 27 | issue = 3 | pages = 263β272 | date = June 2007 | pmid = 17502773 | doi = 10.1097/jcp.0b013e318059361a | s2cid = 38188832 }}</ref><ref name="pmid29579375">{{cite journal | vauthors = Greenblatt HK, Greenblatt DJ | title = Gabapentin and Pregabalin for the Treatment of Anxiety Disorders | journal = Clinical Pharmacology in Drug Development | volume = 7 | issue = 3 | pages = 228β232 | date = March 2018 | pmid = 29579375 | doi = 10.1002/cpdd.446 | s2cid = 4321472 | doi-access = free }}</ref> Gabapentin is effective for the long-term treatment of [[social anxiety disorder]] and in reducing [[Preoperational anxiety|preoperative anxiety]].<ref name="NIHR Evidence_2022">{{cite journal |date=17 October 2022 |title=Review finds little evidence to support gabapentinoid use in bipolar disorder or insomnia |url=https://evidence.nihr.ac.uk/alert/review-finds-little-evidence-support-gabapentinoid-use-bipolar-disorder-or-insomnia/ |journal=NIHR Evidence |type=Plain English summary |publisher=National Institute for Health and Care Research |doi=10.3310/nihrevidence_54173|s2cid=252983016 |url-access=subscription }}</ref><ref name="Hong_2022">{{cite journal | vauthors = Hong JS, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A | title = Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale | journal = Molecular Psychiatry | volume = 27 | issue = 3 | pages = 1339β1349 | date = March 2022 | pmid = 34819636 | pmc = 9095464 | doi = 10.1038/s41380-021-01386-6 }}</ref> In a controlled trial of breast cancer survivors with anxiety,<ref name="pmid29579375"/> and a trial for social phobia,<ref name="pmid17502773"/> gabapentin significantly reduced anxiety levels. For [[panic disorder]], gabapentin has produced mixed results.<ref name="pmid29579375" /><ref name="pmid17502773" /><ref name="Hong_2022" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)